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Abstract
It is well known that the adult human thymus degenerates into fat tissue; however, it has never been considered as a
potential source of angiogenic factors. Recently, we have described that this fat (TAT) produces angiogenic factors and
induces human endothelial cell proliferation and migration, indicating its potential angiogenic properties.
Design: Adult thymus fat and subcutaneous adipose tissue specimens were obtained from 28 patients undergoing cardiac
surgery, making this tissue readily available as a prime source of adipose tissue. We focused our investigation on
determining VEGF gene expression and characterizing the different genes, mediators of inflammation and adipogenesis,
and which are known to play a relevant role in angiogenesis regulation.
Results: We found that VEGF-A was the isoform most expressed in TAT. This expression was accompanied by an
upregulation of HIF-1a, COX-2 and HO-1 proteins, and by increased HIF-1 DNA binding activity, compared to SAT.
Furthermore, we observed that TAT contains a high percentage of mature adipocytes, 0.25% of macrophage cells, 15% of
endothelial cells and a very low percentage of thymocyte cells, suggesting the cellular variability of TAT, which could explain
the differences in gene expression observed in TAT. Subsequently, we showed that the expression of genes known as
adipogenic mediators, including PPARc1/c2, FABP-4 and adiponectin was similar in both TAT and SAT. Moreover the
expression of these latter genes presented a significantly positive correlation with VEGF, suggesting the potential
association between VEGF and the generation of adipose tissue in adult thymus.
Conclusion: Here we suggest that this fat has a potential angiogenic function related to ongoing adipogenesis, which
substitutes immune functions within the adult thymus. The expression of VEGF seems to be associated with COX-2, HO-1
and adipogenesis related genes, suggesting the importance that this new fat has acquired in research in relation to
adipogenesis and angiogenesis.
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Introduction
It has been shown that the thymus grows rapidly during
embryonic life and during childhood, reaching its maximum
absolute size in puberty; thereafter growth ceases and involutes
gradually until old age, when the gland is often smaller than at birth
[1]. This age involution is shown by a decrease in the overall weight
of the organ, associated lymphoid tissue atrophy and replacement
by mature adipose tissue [1]. For this reason, all the studies carried
out on adult thymus involution have been focused primarily on the
immunological aspect, but has never been considered interesting
enough to be studied as a potential source of humoral and
angiogenic factors. Part of this tissue is discarded in aortic
cannulation procedures of the ascending aorta in cardiovascular
surgery in patients in need of a cardiopulmonary bypass (CPB),
making this tissue a readily available prime source of adipose tissue.
Vascular endothelial growth factor (VEGF) is the first member
of angiogenic factors to be cloned and remains today the best-
characterized angiogenic growth factor [2]. VEGF was first
described as a vascular permeability factor [3] but has also been
recognized as being a potent stimulator of endothelial proliferation
and migration [4]. Gene targeting studies have demonstrated the
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angiogenesis [5]. It has been demonstrated that white adipose
tissue produces and secretes many different types of proangiogenic
factors, such as VEGF-A and VEGF-B, the two key angiogenic
factors produced by adipocytes [6]. Other adipose-tissue derived
factors with pro-angiogenic properties are VEGF-C and VEGF-D,
which have been found to be important in the proper formation
and maintenance of the lymphatic network [7]. As a result, VEGF
has been used in numerous preclinical and early clinical gene or
protein therapy trials with varying degrees of success [8].
We have recently found that thymus fat produces a variety of
angiogenic factors such as Angiopoietin (Ang), Tie2, VEGF,
VEGF-R1 and VEGF-R2. Furthermore, human umbilical cord
endothelial cells cultured in the presence of thymus fat extract
displayed enhanced proliferative and migratory responses, which
are two relevant steps in angiogenesis [9]. These findings lead us to
believe that TAT is an interesting source of angiogenic factors
which may, in the future, have a relevant role in promoting
angiogenesis and tissue repair. To complete our previous study [9],
we performed a comparative evaluation of VEGF expression in
human thymus (TAT) and subcutaneous (SAT) adipose tissues. As
angiogenic regulation is usually associated with inflammatory and
anti-inflammatory mechanisms involving cyclooxygenase-2, heme
oxygenase-1 and hypoxia-induced factor-1 transcription factors,
we tested the hypothesis that VEGF expression could correlate
with these markers.
Materials and Methods
Patients and Adipose Tissue Collection
This study was approved by the local ethical committee of
Hospital Carlos Haya, and signed informed consent was obtained
from all participating patients by the Spanish Society of Thoracic
and Cardiovascular Surgery (SECTCV). The number of patients
studied was 28. The mean age was 70.262.7 years. All patients
received a coronary-artery bypass graft (CABG) with cardiopul-
monary bypass (CPB). The mean number of grafts used was 3.1
per patient. The relevant clinical and metabolic characteristics of
these subjects are shown in supplemental Table S1. Both
subcutaneous and thymus adipose tissues were obtained at the
beginning of the procedure. The site of subcutaneous fat harvest
was from the chest incision. Parts of these tissues were stored at
280uC, and the remainder was processed for the immunohisto-
chemistry study.
Real-Time PCR
The amplifications were performed using a MicroAmp optical
96-well reaction plate (PE Applied Biosystems) on an ABI 7500
Real-Time PCR System (Applied Biosystems). RT qPCR
reactions were carried out for all genes using specific TaqManH
Gene Expression Assays. During PCR the Ct values for each amplified
product were determined using a threshold value of 0.1. The
specific signals were normalized by constitutively expressed
cyclophilin (Cyc) signals using the formula 2-DCt.
Preparation of Nuclear and Cytopasmic Protein Extracts
The thymus tissue sample (100 mg) was homogenized in cold
phosphate-buffered saline (PBS), containing protease inhibitors,
and the homogenate was centrifuged at 12,0006g for 45 min to
obtain a clear crude extract, and the resulting pellet was lysed with
NE-PER Nuclear and Cytoplasmatic Extraction Reagents protocol (Pierce
Biotechnology). Briefly, 200 ml of buffer CER I supplemented with
protease inhibitors were added to the homogenate and then
sonicated on ice for 20 seconds and then incubated on ice for a
further 10 min. The homogenate with 10 ml of CER II buffer was
centrifuged at 12,0006g for 10 min at 4uC. The supernatant,
which represents a cytoplasmic fraction, was separated from the
pellet, which represents nucleic fraction. This was then resus-
pended and sonicated on ice in 50 ml of NER buffer and then
centrifuged for 10 min at 12,0006ga t4 uC. The supernatant
represents nucleic soluble fraction. Both fractions of the cytosolic
and nuclear extracts were stored at 280uC.
Western Blot Analysis
Protein extracts (30 mg) were separated by SDS-PAGE, blotted
onto a PVDF membrane and then incubated with specific
antibodies. Protein signals were detected by electrochemilumines-
cence detection Quantity One H software (Bio-Rad Laboratories).
Electrophoretic Mobility Shift Assay (EMSA)
Oligonucleotides were 39 end-labeled with Biotin using terminal
deoxynucleotidyl transferase (TdT), according to the Biotin 39 End
DNA Labeling Kit protocol (Pierce). EMSA was performed using
double-stranded oligonucleotide probes spanning positions +563
to +575 of the VEGF promoter region containing both HRE
(binding site for hypoxia inducible factor-1, [HIF-1]) (+533 to
+549). Labeled oligonucleotides were incubated with nuclear
lysate from different AT’s (10 mg total protein) for 20 min at room
temperature and separated by electrophoresis on a 6% non-
denaturing polyacrylamide gel. DNA-protein complexes were
transblotted onto nylon membranes, developed by ECL using the
LightShiftH Chemiluminescent EMSA Kit (Pierce). For super shift,
proteins were incubated with anti-HIF-1a and anti-p65 mAb for
1h at 4uC prior to the binding assay.
Immunohistochemistry of Adipose Tissue
For the immunostaining process, adipose tissue sections (25mm)
were first fixed for 30 minutes with formol, and washed in 0.1 M
PBS, pH 7.4 for 15 minutes. The sections were treated with PBS
containing 10% methanol and 10% hydrogen peroxide for 30 min
to quench endogenous peroxidase activity and then exposed
overnight to the primary antibodies. Washed sections were then
incubated with the appropriate biotinylated secondary antibodies,
immunoglobulin (Ig) was applied for 1 h and 30 min for
Extravidin-peroxidase. The color was developed by adding
peroxidase substrate 3,39-diaminobenzidine. Sections were coun-
terstained with Mayer’s Hematoxylin and, finally, mounting
solution and cover slips were added.
Flow Cytometry
Cells were labeled with monoclonal antibodies to cell surface
markers directly fluorochrome-conjugated and fixed in 1%
paraformaldehyde. All the antibodies were fluorescein isothiocy-
anate (FITC)-conjugated (CD11b, ITGAM, EMR1, CD45, CD31
CD49, CD8, CD4 and FABP-4). Samples were acquired
immediately or stored at 4uC and acquired within 36 h. The
labeled cells were washed and re-suspended in PBS. Percentage of
positive cells, which indicates the ratio of positive-to- background
staining, was analyzed on a dual-laser BD FACSCalibur
TM.
Statistical Analysis
SPSS Inc. software (Version 15.0) was used for all statistical
analyses. Comparisons between the normalized mRNA levels of
different tissues were made by means of ANOVAs test. The
correlation analysis of mRNA quantitative expression by each of
the genes was performed with Pearson’s correlation coefficient
Test (r).
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PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8213Figure 1. VEGF isoforms mRNA and protein expression in TAT and SAT. TaqManH real time PCR for VEGF isoforms (VEGF A, VEGF-B, VEGF-C
and VEGF-D) was performed on human thymus (TAT) and subcutaneous (SAT) adipose tissues. VEGF isoforms mRNAs were normalized to cyclophilin
(Cyc) levels (A). Results were expressed as the mean6SEM of the completed experiment in triplicate (n=26). Immunoblot analysis of VEGF isoforms.
Densitometry analyses are presented as a relative ratio of VEGF isoforms to actin-b. Bars represent mean6SEM from 6 samples per adipose tissue
type. Bars with different letters have a significant difference, P,0.05 (B).
doi:10.1371/journal.pone.0008213.g001
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VEGF Isoform Levels in Human Thymus and
Subcutaneous Adipose Tissues
qPCR analysis showed that VEGF-A was the angiogenic factor
most expressed in both TAT and SAT, followed by VEGF-B
which was expressed by about 0.70 fold in TAT more than in SAT
(Fig. 1A). However, VEGF-C and VEGF-D expression levels were
very low compared to VEGF-A levels in both AT’s. Western
blotting analysis showed that in both TAT and SAT only VEGF-A
(21kDa) and VEGF-B (64kDa) protein bands were detected
(Fig. 1B), however no protein bands corresponding to VEGF-C
and VEGF-D molecular weights were observed. Immunohisto-
chemical analysis showed that in TAT, a considerable positive
reaction for VEGF-A, VEGF-B and VEGF-C was detected;
however in SAT we could only observe a positive reaction for
VEGF-A and VEGF-B isoforms (Fig. 2). On the other hand, a
strong positive correlation was found between VEGF-A and
VEGF-C in TAT (r=0.803, p,0.005). In SAT, a positive
correlation was detected between VEGF-A and VEGF-B
(r=0.132, p,0.005), suggesting that TAT seems to have both
angiogenic and lymphangiogenic properties.
TAT Expressed High Levels of both COX-2 and HO-1
Compared to SAT
In order to ascertain whether the expression of VEGF isoforms
could be accompanied by inflammatory or anti-inflammatory
mechanisms, we analyzed COX-2 and HO-1 levels in whole AT.
Figure 3A shows that TAT significantly expressed high levels of
COX-2 compared to SAT (p,0.05), while similar levels of HO-1
mRNA were detected in both AT’s (Fig. 3B). Western blotting
analyses show statistically significant (p,0.05) higher protein levels
of both COX-2 and HO-1 in TAT compared to SAT where
COX-2 and HO-1 protein levels were reduced by about 3.5 and
1.4 fold, respectively (Fig. 3C). Furthermore, immunostaining
analyses show a positive reaction for COX-2 in the two AT’s
(Fig. 3D). Moreover, in TAT, a significant and strong correlation
was found between VEGF isoforms and both COX-2 and HO-1
[r(COX-2,VEGF-A)=0.66, r(HO-1,VEGF-B)=0.50, p,0.05] (Table 1),
suggesting a potential connection between the mechanisms
mediated by COX-2, HO-1 and VEGF-A/B expressions.
However, no significant positive correlations were found between
VEGF isoforms and COX-2 and HO-1 in SAT (Table 1).
Inflammatory and Anti-Inflammatory Marker Levels and
the Degree of Macrophage Infiltration in TAT and SAT
In order to determine whether the high levels of COX-2
observed in TAT are the result of an elevated resident
macrophage number in this AT, we analyzed the expression of
classic inflammation markers, including monocyte chemoattrac-
tant protein-1 (MCP-1), a recruiting factor for circulating
monocytes, chemokine macrophage inflammatory protein-1 alpha
(MIP-1a), and macrophage markers CD68, CD11b, ITGAM,
Figure 2. Immunohistochemical identification of VEGF iso-
forms. (a) Negative controls with blue labeling corresponding to
haematoxylin labeled nucleus (arrows). (b) VEGF-A, VEGF-B, VEGF-C
and VEGF-D positive cells from human thymus adipose tissue (arrows).
(c) VEGF-A, VEGF-B, VEGF-C and VEGF-D positive cells from human
subcutaneous adipose tissue (arrows). Positive cells shown with brown
labeling.
doi:10.1371/journal.pone.0008213.g002
Figure 3. COX-2 and HO-1 mRNA and protein expressions in
TAT and SAT. TaqManH real time PCR for COX-2 and HO-1 mRNAs
were performed on human adipose tissues (TAT and SAT). Specific
mRNAs were normalized to cyclophilin (Cyc) levels. Results are
expressed as the mean6SEM of experiment done in triplicate (n=26)
(A and B). Western blotting of COX-2 and HO-1 (C). Immunohistochem-
ical identification of COX-2. Densitometry analyses are represented as a
relative ratio of COX-2 and HO-1 to actin-b. Bars represent mean6SEM
from 6 samples per adipose tissue type. Bars with different letters have
a significant difference (P,0.05) (D).
doi:10.1371/journal.pone.0008213.g003
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TAT have similar mRNA and protein levels of MCP-1 and MIP-
1. Furthermore, real time PCR and immunohistochemical
analyses showed that all macrophage markers were also expressed
equally in the two AT’s (Fig. 4E), suggesting that the high levels of
COX-2 observed in TAT are probably not due to the infiltration
of a high number of resident macrophages in this AT, since the
markers of this last fact were similar in both AT’s.
On the other hand, and considering the cellular heterogeneity of
TAT which would be responsible for the differentially expressed
genes, we performed a flow cytometric analysis in order to
determine the percentage of each cellular population. We observed
that TAT contains a high proportion of cells that express FABP-4,
which is a good marker of mature adipocytes [10] (Table 2).
Macrophage cells, which showed a positive staining for CD11b,
ITGAMand EMR1represent about 0.25%of totalthymusfatcells,
endothelial cells about 15% and a very low percentage of thymocyte
cells (0,05%). Next we analyzed the expression of genes known as
mediators of adipogenesis, including PPARc1, PPARc2, FABP-4
and adiponectin in both TAT and SAT.
PPARc1, PPARc2, FABP-4 and Adiponectin in Both SAT
and TAT
Fig. 5A shows for the first time that TAT expresses both PPARc
isoforms (PPARc1 and PPARc2) with considerable levels compared
Table 1. Correlation coefficients of VEGF isoforms withFABP-4, Adiponectin, PPARc1/2, HIF-1a, COX-2 and HO-1.
Correlation coefficient, r
N=26 TAT SAT
Variables VEGF isoforms VEGF isoforms
ABCDABCD
FABP4 0.49
* 0.81
* 0.23 0.42 0.84 20.10 20.42 0.93
ADIP 0.69
* 0.58
* 0,18 0.24 0.40 20.53 0.28 20.04
PPARc1 0.51 0.33 20.04 0.03 0.68
* 0.36 0.39 0.66
PPARc2 0.63* 0.54* 0.12 0.31 0.72
* 0.25
* 0.46
* 0.71
HIF-1a 0.38
* 0.20
* 20.02 20.71 20.14 20.22 0.41 0.32
COX-2 0.66
* 0.19
* 0.98
* 0.07 0.46 0.54 20.26 0.32
HO-1 0.20
* 0.50
* 0.66
* 0.70 20.64 0.34 0.57 20.15
Correlation of VEGF isoforms mRNA expression with FABP-4, adiponectin (Adip), PPARc1/2, COX-2 and HO-1 was determined by Spearman’s correlation coefficient test
(r). Strong correlation was demonstrated between VEGF isoforms and FABP-4, Adiponectin, PPARc2, COX-2 and HIF-1a in thymus adipose tissue (TAT). However, with
subcutaneous (SAT) adipose tissue a strong correlation was only detected between VEGF isoforms and PPARc1/2. *p,0.05.
doi:10.1371/journal.pone.0008213.t001
Figure 4. MCP-1, MIP-1a, ITGAM, EMR-1, CD68 and ADAM-8
mRNA and protein expression in TAT and SAT. TaqManH real time
PCR for MCP-1, MIP-1a, ITGAM, EMR-1, CD68 and ADAM-8 mRNAs was
performed on human adipose tissues (TAT and SAT). Specific mRNAs
were normalized to cyclophilin (Cyc) levels. Results are expressed as the
mean6SEM of experiment carried out in duplicate (n=26) (A,D). Western
blotting of MCP-1 and MIP-1a. Densitometric analyses are represented
as a relative ratio of MCP-1 and MIP-1a to actin-b. Bars represent
mean6SEM from 6 samples per adipose tissue type(B and C).
doi:10.1371/journal.pone.0008213.g004
Table 2. Percentage of cell staining for cellular surface
markers from adult thymus fat based on flow cytometric
analysis.
Cell surface marker % of positive cells
FABP-4 (Fatty acid binding proteins) 64.367,231
CD11b, ITGAM, EMR1 (Macrophage markers) 0.2560.002
CD45, CD31 (endothelial cell markers) 15.862.010
CD49, CD8, CD4 ( thymocyte markers) 0.0560.001
The data represents the mean of three experiments6SD. Each experiment
consisted of a pool of cells from adult human thymus fat.
doi:10.1371/journal.pone.0008213.t002
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ratio, we observed similar values (PPARc2/c1=0.51860.02) in
both AT’s. On the other hand, strong correlations between VEGF-
A and VEGF-B mRNA expression and PPARc isoforms were only
observed in SAT, [r(PPARc1,VEGF-A)=0.68, r(PPARc1,VEGF-B)=0.36,
r(PPARc2,VEGF-A)=0.72; r(PPARc2,VEGF-B)=0.25, p,0.05] (Table 1).
By performing Western blot analysis on the two adipose tissues
using antibodies specific for PPARc, we could confirm the results
obtained by quantitative mRNA expression analysis (Fig. 5B).
Furthermore, expression analysis of adiponectin and FABP-4,
genes known to regulate the adipogenesis process, demonstrated
that both showed similar expression levels in both SAT and TAT
(Fig 5C).
HIF-1a mRNA and Protein Expression and DNA-Binding
Activities of HIF-1a in TAT and SAT
Hypoxia is known to induce angiogenesis, linking vascular
oxygen supply to metabolic demand [11]. In recent years,
accumulating evidence highlights the notion that hypoxia may
exist in fat deposits as the tissue mass increases [12]. Here, mRNA
expression analysis demonstrates that HIF-1a gene expression was
induced equally in the two adipose tissues (Fig. 6A). Also, western
blot analyses shows high levels of HIF-1a indicating the stability of
this protein in both AT’s (Fig. 6B), which signifies that both TAT
and SAT seem to have similar hypoxic characteristics. On the
other hand, a positive and significant correlation between VEGF
isoforms and HIF-1a was observed in TAT (r=0.38, p,0.05),
while no significant positive correlation between VEGF-C and
HIF-1a was found in SAT (Table 1), suggesting the potential
relationship between HIF-1 and VEGF expression regulation. For
this reason we subsequently examined the binding activity of HIF-
1 to the putative HRE-binding consensus in the promoter region
of human VEGF gene by EMSA. As shown in figure 6C, nuclear
extracts from TAT showed higher binding activity of HIF-1a to
HRE consensus from the VEGF human gene promoter in TAT
compared to SAT where the intensity of the shift bands was minor.
The addition of anti-HIF-1a mAb resulted in an obvious super
shift indicative of the union of HIF-1a to the DNA consensus
region, suggesting the high DNA binding activity of HIF-1a
transcription factor in TAT. As controls, nuclear extracts were
incubated with a 100-fold excess unlabeled primer which resulted
in complete loss of signal (data not shown).
Figure 5. PPAR-c FABP-4 and adiponectin mRNA and protein
expression in TAT and SAT. TaqManH real time PCR for PPAR-c
isoforms (PPAR-c1 & PPAR-c2) and FABP-4 and adiponectin was
performed on TAT and SAT human tissues. PPARc isoforms mRNAs
were normalized to cyclophilin (Cyc) levels. Results are expressed as the
mean6SEM of experiment done in duplicate (n=26) (A and C).
Immunoblotting analysis of PPARc. Densitometry analyses are repre-
sented as a relative ratio of VEGF isoforms to actin-b. Bars represent
mean6SEM from 6 samples per adipose tissue type. Bars with different
letters have a significant difference, P,0.05(B).
doi:10.1371/journal.pone.0008213.g005
Figure 6. Hypoxia induced Factor -1a (HIF-1a) mRNA and
protein expression and HIF-1 DNA-binding activity in TAT and
SAT. TaqManH real time PCR for HIF-1a mRNAs were performed on
human adipose tissues (TAT and SAT). Specific mRNAs were normalized
to cyclophilin (Cyc) levels. Results are expressed as the mean6SEM of
experiments in duplicate (n=26) (A). Western blotting of HIF-1a.
Densitometric analyses are represented as a relative ratio of HIF-1a to
actin-b. Bars represent mean6SEM from 6 samples per adipose tissue
type (B). EMSA was performed by incubating AT nuclear extracts with a
biotin labeled consensus HIF-1 probe from the human VEGF promoter
region. Super shift was performed by the prior incubation of adipose
tissue nuclear extract with anti-HIF-1a (super shift) and then EMSA was
carried out by incubating with biotin labeled consensus HIF-1 (C). The
blot is representative of three independent experiments with 8 samples
from each adipose tissue type.
doi:10.1371/journal.pone.0008213.g006
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Most of the studies on thymus fat are focused on immune
senescence and various associated diseases related to atrophy and
involution of this tissue [13]. Adult thymus specimens were
obtained from cardiomyopathy ischemic patients undergoing
cardiac surgery, due to the fact that part of this tissue is discarded
in aortic cannulation procedures of the ascending aorta in
cardiovascular surgery for patients in need of a cardiopulmonary
bypass (CPB). However, until now, no studies have been carried
out that consider thymus fat as a potential source of humoral and
angiogenic factors, that could help in heart neovascularization
after a cardiopulmonary bypass (CPB). Our idea is that thymus fat
tissue and derived cells could serve as an angiogenic source which
could help in the regeneration of new vessels in the ischemic
myocardium. This hypothesis should be rigorously analyzed by
studying the expression of the different angiogenic factors and
especially those which are known to play relevant roles in
angiogenesis and the generation of new vessels, and the molecular
mechanisms that could have a crucial role in angiogenesis
regulation in TAT. Here we present a preliminary and
observational study which reveals the activation of a variety of
genes and proteins generally known to be involved in inflamma-
tory and anti-inflammatory processes and also in the regulation of
angiogenic factors, especially the VEGF. Recently, we showed that
thymus AT contains significant levels of a variety of angiogenic
factors. Furthermore, developing cell migration and proliferation
assays in which umbilical cord endothelial cells were evaluated for
their ability to migrate and to proliferate, we observed an increase
in proliferative and migratory activities in the presence of thymus
extract [9], which are two relevant steps in angiogenesis,
suggesting the angiogenic capacity of TAT. In the present work
we observed that TAT expresses high levels of adipogenesis
mediated genes, suggesting the generation of new adipose tissue in
the thymus gland at old age. The expression of these adipogenic
genes and those regulators of inflammation correlate positively
with VEGF, suggesting the possible implication of these genes in
VEGF regulation.
It is well known that over-expression of VEGF- A and VEGF- B
has been associated with increased angiogenesis [14], while
VEGF-C and VEGF-D are lymphangiogenic factors [15]. Here,
evaluating the expression of VEGF isoforms, we found that TAT
seems to have both angiogenic and lymphangiogenic properties,
while SAT seems to be especially an angiogenic source, because
VEGF-C expression was mostly detected in TAT. This VEGF-C
positive staining suggests that the expression of this VEGF isoform
could be related to the stromal lymphopoietin activity of Hassall’s
corpuscles that could conserve thymus AT [13]. In fact, here we
could clearly appreciate the presence of these corpuscles after
immunohistochemistry staining (data not shown), but we also
observed that TAT showed a structure characterized by unilocular
adipocytic cells such as subcutaneous adipose tissue. The next
proposal of our study was to analyze whether VEGF expression
could be accompanied by COX-2, a protein relevant in regulating
pro-inflammatory processes, and HO-1, one of the most potent
cytoprotector proteins, which have been demonstrated to play a
relevant role in VEGF regulation [16]. In fact, works have shown
that COX-2 promotes angiogenesis [17], and up-regulates VEGF
expression [18]. Others have shown that HO-1 mediates VEGF
stimulated angiogenesis [19]. Here we found that in the two AT’s,
a significant expression of COX-2 and HO-1 was detected,
especially in TAT, suggesting that TAT displays the activation of
both inflammatory and cytoprotective processes. Also the strong
positive correlation of COX-2 and HO-1 with VEGF expression
could suggest the potential relationship between these three
proteins in TAT. These data have to be confirmed in future
experiments, where signaling pathways should be well defined.
If we want to demonstrate that TAT is a white adipose tissue we
have to define the different cell populations that constitute this
tissue in order to determine whether we are studying a tissue that is
100% adipose or if it conserves its thymopoietic characteristics.
For this end, we performed a cytometric analysis to characterize
the different cell populations that constitutes TAT. As expected,
TAT has a similar cellular profile as another white adipose tissue;
in fact it contains a large amount of pre-adipocytes and adipocytes,
a percentage of 15% of endothelial cells and 0.25% of
macrophages. However and as expected, we could barely observe
thymocytes either by cytometric analysis or by immunohistochem-
istry. Also, immunohistochemistry analysis showed a similar
cellular structure as that observed in any other white adipose
tissue. These data suggest that instead of talking about the
degeneration of the thymic gland we should talk about the
generation of new adipose tissue which replaces the generation of
thymocytes. Also, the profile of gene expressions observed above
could be the results of the presence of a variety of cell type in TAT.
We believe that in the near future new experiments should be
done in order to ascertain whether VEGF, COX-2 and HO-1
expressions are exclusive to adipocytes or other cells as
macrophages and endothelial cells are involved in this genetic
profile observed in whole TAT.
On the other hand, here we show that thymus tissues
degeneration at old age is rather a substitution of thymocytes by
adipocytes, indicating the presence of neo-generation mechanisms
of new adipose tissue which is adipose tissue. In fact the analysis of
the expression of a variety of genes known to be relevant mediators
of adipogenesis and lipogenesis (PPARc, adiponectin and FABP-
4)(10,20–22), showed that both PPARc1 and c2 are expressed in
both AT’s. PPARc2 is especially expressed in fat while PPARc1i s
expressed in fat and other tissues [20]. Recent works have
demonstrated that PPARc2 has a high adipogenic activity in
adipose tissue [21,22]. Also, adiponectin and FABP-4, two relevant
adipogenesis mediators [10,23], showed similar expression levels in
TAT compared to those observed in SAT. Taken together, all
these data show for the first time that TAT has adipocytic
properties like other AT’s. Furthermore, positive correlations were
observed between PPARc2, adiponectin, and FABP-4 expressions
and VEGF-A and VEGF-B gene expressions, suggesting that the
expression of these angiogenesis-related genes observed in this
study could be largely localized in adipocytes than in other cell
types such as macrophage or endothelial cells. Future experiments
should be carried out to confirm this hypothesis, by separating the
different cell types that constitute TAT and analyzing the
expression of these genes in each one. Here we anticipate that
both macrophages and adipocytes seem to have a potential role in
the observed VEGF expressions, because strong positive correla-
tions are also found between adipogenesis markers (PPARg2,
adiponectin and FABP-4) and VEGF gene expression [r(PPARg2,
VEGF-B)=0.78*, r(FABP-4,VEGF-B)=0.45**, r(adiponectin,
VEGF-A)=0.61**, **p,0.01 and *p,0.05)]. And also positive
correlations are found between macrophage markers (MCP-1,
ITGAM and EMR1) and VEGF gene expressions [r(MCP-1,
VEGF-B)=0.38**, r(ITGAM,VEGF-A)=0.53*, r(EMR-1,
VEGF-A)=0.49*, **p,0.01 and *p,0.05)].
Also, in this study we analyzed another factor that characterizes
adipose tissue, hypoxia induced factor-1(HIF-1). It is well known
that adipose tissues show low oxygen pressures [12]. Furthermore,
HIF-1 is a transcription factor that has been shown to be essential
for VEGF transcriptional activation [24]. Here we found that
Degenerated Thymus New Role
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than from SAT, suggesting the potential implication of this
transcription factor in the regulation of VEGF, especially in TAT.
These results were confirmed by the detection of high levels of
HIF-1a protein and a strong positive correlation between VEGF
and HIF-1a in TAT. On the other hand, we found a significant
positive correlation between HIF-1a and COX-2 [r(COX-2, HIF-1)
=0.54, p,0.05) in TAT, suggesting the potential relationship
between these two proteins in TAT. In conclusion, the fact that
VEGF showed a positive correlation between both COX-2 and
HIF-1 could lead us to believe that these two proteins may have a
potential role in regulating VEGF, since in some white adipose
tissues many authors have explained that VEGF activation
implicates COX-2 gene expression activation through HIF-1a
[25], because it has been observed that the COX-2 gene is directly
transcriptionally activated in response to hypoxia by HIF-1
binding to a functional HRE within the proximal COX-2
promoter [26], and that COX-2 over-expression stimulates the
expression of HIF-1, which in turn induces continued COX-2
expression [27].
Here we can conclude that adult thymus fat is an interesting
source of angiogenic factors, which was previously unappreciated.
Most studies have shown that the thymus loses its function during
old age. With the data presented in this work we should say that
the thymus replaces its immune function by another which is that
of an ordinary white adipose tissue.
Moreover, it is evident that thymus fat presents a similar cellular
profile as that observed in other white adipose tissues such as SAT.
This cellular variety seems to be responsible for the observed
differences in the expression of a variety of genes that are known to
be relevant in the regulation of angiogenesis and adipogenesis in
other white adipose tissues.
VEGF gene expression seems to be related to both adipocytes
and macrophages, since the markers of these two cell types show a
significant and strong correlation with VEGF gene expression in
TAT. Also, this VEGF expression appears to be also associated
with COX-2 and HIF-1 expression and activation in TAT. Our
future objective is to well define the molecular mechanisms
mediated by these proteins that could play a crucial role in VEGF
regulation, in whole thymus adipose tissue and separately in each
cell population.
One may wonder why use this thymus fat as a source of
angiogenesis having access to other body fats such as subcutaneous
and visceral adipose tissues. Firstly, as we mentioned previously, part
ofthisfat isdiscarded during CBPsurgery,and the resultsobtained in
t h i sa n dp r e v i o u sw o r k s[ 9 ]i n d i c a t et h a tt h i st i s s u ed e s e r v e st ob e
studied in depth in order to investigate its potential usefulness as an
adipose tissue. Furthermore, there are no adverse effects of removing
this fat, because in our clinical experience these procedures had no
surgical complications or morbidity associated. On the other hand,
the largest source of thymus adipose tissue are ischemic patients,
because part of this tissue used to be discarded in aortic cannulation
procedures of the ascending aorta in cardiovascular surgery in
patients in need of a cardiopulmonary bypass (CPB), and this is a
procedure frequently used by cardiac surgeons [28,29]. Furthermore,
the studies done on thymus fat and thymus function are based in the
vast majority in excising and removing thymus fat during cardiac
interventions, which shows how often this practice is carried out, and
its safety. Moreover, we are of the opinion that this fat could, in the
future, provide much needed help in heart neovascularization after a
cardiopulmonary bypass interventions (CPB), especially for patients
who cannot benefit from coronary revascularization treatment after
surgery or angioplasty [30].
Supporting Information
Table S1 Clinicopathological characteristics and biomarker
parameters in Ischemic Cardiomyopathy patients. The number
of patients studied was 28. The mean age was 70.262.7 years. All
patients received a coronary-artery bypass graft (CABG) with
cardiopulmonary bypass (CPB). The mean number of grafts used
was 3.1 per patient Values are presented as means6SE.
Found at: doi:10.1371/journal.pone.0008213.s001 (0.03 MB
DOC)
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